Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data IMMUTEP Ltd files with the SEC in its annual reports.
In AUD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2016
FY2018
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
2.03
4.22
7.35
7.49
16.5
3.97
6.76
5.2
7.84
10.3
Research and development
7.06
7.53
9.99
13.8
15.6
12
25.3
28.8
31.5
49.8
General and administrative
2.92
2.15
2.52
2.78
2.86
2.82
3.32
3.71
4.23
3.55
Interest expense
0.01
0
0.01
0.01
0.09
0.02
0.03
0.04
Pre-tax income
-63.2
-10.1
-12.7
-18.3
-13.5
-29.9
-32.2
-39.9
-42.7
-61.4
Income tax
-1.18
-0.74
0
0
0
0
0
0
0
0
Net income
-62
-9.37
-12.7
-18.3
-13.5
-29.9
-32.2
-39.9
-42.7
-61.4
EPS, basic
-0.26
-0.04
-0.05
-0.05
-0.03
-0.05
-0.04
-0.04
-0.04
-0.04
EPS, diluted
-0.26
-0.04
-0.05
-0.05
-0.03
-0.05
-0.04
-0.04
-0.04
-0.04
Balance sheet
FY2016
FY2018
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
20.9
12.2
23.5
16.6
26.3
60.6
80
123
162
67.4
Short-term investments
0
20.1
62.3
Receivables
2.19
3.43
5.19
3.29
6.12
8.37
7.95
7.35
9.87
Total current assets
15.9
28.6
23.5
31.2
68.4
90.8
135
191
149
Property, plant and equipment
0.03
0.02
0.03
0.05
0.05
0.04
0.04
0.08
0.06
0.06
Lease right-of-use assets
0
0.2
0.27
0.27
0.39
0.62
0.51
Total assets
42.6
35
47
40.5
46.6
82
102
147
202
157
Accounts payable
2.59
3.66
5.06
2.93
4.78
5.75
9.02
9.56
10.6
Total current liabilities
2.63
3.85
5.3
3.36
5.34
6.41
9.77
10.5
12.8
Lease liabilities
0
0.13
0.08
0.11
0.21
0.4
0.31
Total liabilities
7.24
8.43
13.5
16.2
13.3
8.76
8.09
11
12.1
13.3
Retained earnings
-232
-245
-262
-276
-275
-302
-340
-383
-444
Shareholders' equity
26.5
33.5
24.4
33.3
73.3
94.1
136
190
144
Total equity
35.3
26.5
33.5
24.4
33.3
73.3
94.1
136
190
144
Total liabilities and equity
42.6
35
47
40.5
46.6
82
102
147
202
157
Cash flow statement
FY2016
FY2018
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
-62
-9.37
-12.7
-18.3
-13.5
-29.9
-32.2
-39.9
-42.7
-61.4
Depreciation and amortization
1.99
1.7
1.81
1.88
2.08
2.07
2.06
2.06
2.26
2.39
Cash from operations
-11.3
-8.51
-7.78
-15.3
-10.8
-17.6
-30.2
-35.4
-34.8
-62
Capital expenditures
-0.03
-0.01
-0.01
-0.04
-0.02
-0.02
-0.02
-0.08
-0.03
-0.05
Cash from investing
0.1
-0.01
-0.01
-0.04
-0.02
-0.02
-0.02
-0.08
-21
-38.5
Debt repaid
-1.51
Cash from financing
25.7
-0.01
18.4
8.01
20.5
52.7
50.3
76
95.2
-0.53
Exchange rate effect
-0.39
-0.12
0.62
0.41
0.13
-0.75
-0.67
2.84
-0.97
6.73
Free cash flow
-11.3
-8.51
-7.79
-15.3
-10.9
-17.7
-30.3
-35.4
-34.9
-62.1
Interest paid
0.01
0.09
0.02
0.03
0.04
Income taxes paid
0
-0.02
0
0
0
0
0
0
0
0
Key metrics
Worked out from the statements above. Latest values use fiscal 2025. No valuation: the share price is quoted in a different currency than the statements.
Profitability
Metric
Value
How it is calculated
Pre-tax margin
-594.6%
Pre-tax income / revenue.
Net margin
-594.6%
Net income / revenue.
FCF margin
-601.0%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
-600.6%
Cash from operations / revenue.
Return on equity (ROE)
-36.9%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-34.3%
Net income / average total assets.
R&D / revenue
481.8%
Research and development expense / revenue.
Capex / revenue
0.4%
Capital expenditures / revenue.
D&A / revenue
23.1%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
31.8%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
15.2%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
-8.9%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y
-24.2%
Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y
15.1%
Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y
34.0%
Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y
-22.1%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
15.4%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
27.5%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
11.7x
Current assets / current liabilities.
Quick ratio
10.9x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
10.2x
(Cash + short-term investments) / current liabilities.
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic
-A$0.04
Net income per basic share, as reported (split-adjusted).
What was IMMUTEP Ltd's revenue in fiscal 2025?
IMMUTEP Ltd reported revenue of A$10.3M for fiscal 2025, 31.8% higher than the year before.
Was IMMUTEP Ltd profitable in fiscal 2025?
No. It reported a net loss of A$61.4M.
How much free cash flow did IMMUTEP Ltd generate in fiscal 2025?
Cash from operations of A$62.0M minus capital expenditures of A$45.8K left free cash flow of -A$62.1M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.